The presented invention is directed to devices, arrangements and associated methods for effectively transporting fluids, for example, samples of body fluids.
In the following discussion certain articles and methods will be described for background and introductory purposes. Nothing contained herein is to be construed as an “admission” of prior art. Applicant expressly reserves the right to demonstrate, where appropriate, that the articles and methods referenced herein do not constitute prior art under the applicable statutory provisions.
According to the American Diabetes Association, diabetes is the fifth-deadliest disease in the United States and kills more than 213,000 people a year, the total economic cost of diabetes in 2002 was estimated at over $132 billion dollars, and the risk of developing type I juvenile diabetes is higher than virtually all other chronic childhood diseases.
In certain medical treatment and diagnostic procedures, it is necessary to transport body fluid from the patient to a remote location. For example, one such procedure is the testing of a sample of body fluid, such as blood, for the glucose concentration level contained therein. Such diagnostic procedures may be conducted clinically or by the patient utilizing a self-testing device or arrangement. There are numerous devices and systems designed to be utilized by the patient for obtaining a sample of blood, and testing the sample to determine the glucose content at a particular point in time. One such system generally includes at least three separate devices. The first device is utilized to draw a sample of blood from the patient by performing a lancing or similar skin piercing operation. Lancets are solid members which do not include a pathway for transporting the sample of blood. Since the lancets do not offer the ability to transport the sample, a separate member or component must be provided for this purpose. Typically, such systems include a separate test strip member which is manually brought into contact with the sample of blood produced by the lancing operation. The sample is then introduced onto the test strip, which includes a mechanism, such as a chemical reagent, for reacting with the blood sample and producing a readable signal. To this end, a separate meter or other reading device is also included in the system. The test strip is typically introduced into the meter, which then interacts with the test strip to produce the quantification of the glucose content contained in the sample of blood.
Such systems suffer from certain drawbacks. The manual operations of lancing, bringing the test strip into contact with the sample of blood thus produced, and the separate step of inserting the test strip into the meter may be difficult to perform for some patients. For instance, diabetics often times suffer from visual impairment as a result of their condition. Thus, it may be difficult for them to locate the sample of blood on the surface of the skin and bring the test strip into communication therewith. Similarly, it may be difficult to properly insert the test strip into the meter. In addition, there is a trend toward minimizing the size of the lancet used to perform the lancing operation in an effort to minimize the pain associated with this self testing procedure, thereby promoting more frequent testing. The use of a smaller gauge lancet also results in a smaller volume of body fluid, or blood, produced by the lancing operation. Such smaller samples of blood may be even more difficult to locate by the patient, and also may be more challenging to transport effectively.
Other systems for self-testing on the market attempt to integrate one or more above described lancing, transporting and quantification operations. One such system requires the user to load a lancet and a test strip into a device, which includes a meter. Once loaded the device is held against the skin and the test initiated by the user, which includes a lancing operation and subsequent transport of a sample of body fluid into the test strip. This arrangement still requires the manual step of loading a separate lancet and test strip correctly into the device, and orienting the device correctly at the surface of the skin in order to perform each test. This device also uses the lancet, which in and of itself does not provide a mechanism to transport the sample of blood. Thus, it is necessary to provide a separate mechanism, which enables transportation of the blood from the surface of the skin to the test strip. In this particular device, the transport function is performed by automatically moving the test strip, which includes capillary channels, into communication with the sample of blood at the surface of the skin. If the test strip is not loaded correctly, or the mechanisms for moving the test strip into position do not function correctly, the device will not function properly. Moreover, the user must purchase, store, handle and load the separate lancet and test strip components for each test. Thus, the successful performance for each test is again at least partially dependent upon the patient correctly associating the lancet and the test strip with the device for each and every test performed.
Yet another conventional self-testing system includes multiple disposable parts for lancing and analyte quantification. In this particular device, a test strip is provided which has an integrated blood transport member in the form of a capillary tube extending from a major planar surface thereof which must be brought into communication with the droplet of blood formed on the surface of the skin resulting from a lancing operation. In order to facilitate the transport function, the test strip is provided with a separate spreading layer sandwiched between the end of the capillary tube and a reagent membrane disposed on an opposing side thereof. The spreading layer facilitates transfer of the blood from the tube to the reagent layer. This system is designed such that a sample volume that completely fills the tube is required in order to obtain an accurate test result. Thus, approximately two micro liters of blood is typically required to be drawn from the patient such that the tube can be completely filled and transferred for further analysis. This requires creation of a wound in the skin large enough to express the necessary volume of blood, thus limiting lancet size reduction efforts. Also, the process of completely filling the tube is time consuming, and may require the user to apply significant efforts to manually express or milk a sufficient quantity of blood from the wound in order to fill the tube. This design also requires the blood to flow through the spreading layer prior to reaching the reagent layer. This two-layer structure is less than optimal from an assembly standpoint (i.e. requiring the assembly of multiple distinct layers), and since the volume of the capillary tube must be first transferred through the spreading layer, this may also have a tendency to slow down the testing procedure and reduce the volume of sample available for analysis. The spreading layer also retains a certain amount of the sample, thereby reducing the amount of the sample that is available for reaction with the reagent layer, and subsequent analysis thereof. Also, the spreading layer can alter certain characteristics of body fluids, such as whole blood. For instance, the spreading layer may alter the hematocrit contained in a sample of whole blood.
Thus, conventional body fluid transport systems for medical treatment and/or diagnostic procedures suffer certain drawbacks. Such drawbacks include transport operations that are reliant upon the dexterity and ability of the patient to accurately perform various manual procedures. The conventional devices and arrangements also are not fully integrated and require significant intervention on the part of the user in order to perform an accurate test.
It is, therefore, an object of this invention to provide devices, arrangements and methods for improved transport of a body fluid, such as blood.
According to the current principles of the present invention, one or more of the following advantages may be derived from such devices, arrangements and methods. Consistent with the principles of the present invention, a body fluid can be transported without the necessity of performing various operations or procedures by the patient or user of the device. Thus, for example, it is unnecessary for the patient or user of the device to manually bring a fluid member in communication with a droplet of blood on the surface of skin.
According to the present invention, it is also unnecessary to provide a body fluid sample having a volume at least large enough to fill a capillary tube or other fluid transport member, thus reducing the time necessary to perform a test as well as providing an opportunity to create a smaller wound in the surface of the skin, and/or reducing or eliminating the need to milk blood from the wound, thereby minimizing pain and inconvenience associated with a lancing or other wound creating procedure.
According to the current principles of the invention, improved fluid transport can be provided by associating fluid transport with a fully integrated device. A fully integrated device formed according to the principles of the present invention provides for a potential lower cost device due to a reduction in distinct components which may be sourced from different vendors, which may provide a reduced manufacturing burden (i.e. reduced packaging, assembly, etc.). According to one aspect of the present invention, a needle serves multiple purposes. Namely, the needle acts as a lancet and a transfer tube, all in a single device. This insures that a sterile lancet is used for each and every test, thereby reducing the risk of infection and/or pain associated with lancet reuse, as well as simplified operation.
A further possible advantage provided by the present invention is the elimination of spreading/filtering media or layers. This advantage eliminates the reliance on a special spreading media, which can reduce the volume of blood available to the reagent, thereby providing an opportunity for even greater sample volume reduction and related pain reduction. The elimination of a spreading/filtering media or layer also simplifies manufacturing by reducing the necessity of correctly positioning a small spreading media layer relative to other components of the assembly. The elimination of the spreading layer also prevents the nature of the sample from being influenced thereby, such as an alteration of the hematocrit contained in the sample.
According to one aspect of the present invention, there is provided an arrangement comprising: a base having a bore disposed therein extending from a first surface of the base through a second surface of the base; a fluid transport tube having a first end, a second end opposite the first end, and a lumen having an inner diameter, at least the second end of the tube being received within the bore of the base; at least one fluid transport enhancing groove comprising at least a first section disposed in the second surface of the base and in fluid communication with the bore.
According to a further aspect, the present invention provides a base having a bore disposed therein extending from a first surface of the base through a second surface of the base; a needle having a first end adapted to pierce the skin, a second end opposite the first end, and a lumen having an inner diameter, at least the second end of the tube being received within the bore of the base; at least one fluid transport enhancing groove comprising at least a first section disposed in the second surface of the base and in fluid communication with the bore; and an analyte quantification member in fluid communication with at least one of the bore and the at least one fluid transport enhancing groove.
According to yet another aspect, the present invention provides a wearable blood glucose monitor comprising any of the arrangements described herein.
The preferred embodiments are illustrated in the drawings in which like reference numerals refer to the like elements and in which:
Devices, arrangements and their associated methods are structured to comprise at least one, or a combination of some or all, of the following characteristics.
An exemplary arrangement 100 formed consistent with the principles of the present invention is illustrated in
The arrangement 100 may further include a base 20. The base 20 may have any suitable geometry or size. In the embodiment demonstrated in
The arrangement 100 includes at least one fluid transport-enhancing groove 30. The fluid transport-enhancing groove 30 is located in the second surface 26 of the base 20. The groove is preferably in fluid communication with the bore 22. The groove 30 may also extend away from the bore 22 to an edge of the second surface 26. The groove 30 may be provided in many different forms. For example, the groove 30 can be provided with a number of suitable geometrical or cross sectional configurations. Non-limiting examples are illustrated in
According to a further optional embodiment of the present invention, grooves 30D formed according to the present invention may have a cross sectional area that varies along its length, as illustrated, for example, in
Grooves formed according the principles of the present invention may also have any suitable dimensions. In general, grooves formed according to the present invention are dimensioned to provide enhanced capillary action upon contact with target fluid, such as whole blood. For purposes of illustration only, grooves formed according to the present invention, which are square or rectangular may have a depth on the order of 0.002-0.020 inches, and a width of 0.002-0.020 inches. Grooves having a curved bottom may be provided with a radius of curvature on the order of 0.002-0.022 inches.
Grooves formed according the principles of the present invention may also comprise an additional fluid flow-enhancing feature disposed on at least a portion thereof. For example, a groove may be provided with a fluid flow enhancing coating. For example, a coating of polydimethaxelane (PDMS), or Silwet™, may be applied to at least a portion of the groove. Alternatively, or in addition to the aforementioned coating, the groove may be formed in the surface of a material having a flow enhancing property inherent thereto. For example, the groove may be cut into the surface of a hydrophilic polymeric material. Alternatively, or in combination with the above, the groove may also be provided with a surface texturing, which promotes fluid flow therein.
Grooves formed according to the principles of the present invention may be formed by any suitable manufacturing technique. For example, grooves formed according to the present invention may be molded or cast in place. Alternatively, the grooves may be cut, by a suitable removal technique, such as laser ablation, a plunge EDM technique utilizing an electrode whose contour would match the desired groove profile, or another suitable micro-machining technique.
It should be understood that the above discussion of the various characteristics, features, and techniques for forming grooves, applies universally to all the grooves described in the present application regardless of the particular arrangement they may be associated with. Thus, the above discussion will not be repeated in connection with every possible alternative embodiment of the present invention described herein, however, the aforementioned features, characteristics and methods of forming the grooves nonetheless applies to all the embodiments described herein.
As illustrated in
An alternative arrangement 300 formed according to the principles of the present invention, is illustrated in
According to the arrangement 300, since the groove originates in the bore 22 at a location which is typically below where a meniscus of the fluid being transported (see, e.g., “M”,
The transition between the first and second sections 30′, 30″ of the groove may have any suitable geometric configuration. According to one alternative embodiment, the transition between the first and second sections 30′, 30″ is rounded or radiused, so as to minimize adverse impacts on capillary flow between first and second sections 30′, 30″ of the groove. As illustrated in
According to further alternative embodiments of the present invention, the number and arrangement of grooves disposed in the second surface 26 of the base 20 may vary according to the principles of the present invention. Five alternative embodiments of such arrangements are depicted, for purposes of illustration, in
As illustrated in
According to a further alternative, one or more grooves may be provided which are in fluid communication with the bore at a location other than at an end thereof. For example, according to the illustrated embodiment depicted in
According to the embodiment depicted in
As illustrated in
According to another embodiment, a groove pattern 180 such as the one illustrated in
The grooves contained in the arrangement 180 may have any suitable dimensions. According to a non-limiting example, the groove(s) 182 may be approximately 0.002 inches wide and 0.002 inches deep, the groove 184 may be approximately 0.005 inches width and 0.010 inches deep, and the groove(s) 188 may have a width of approximately 0.010 inches at the narrow end, with a depth of approximately 0.010 inches.
As previously noted, the grooves associated with the above embodiments of
Another arrangement 190 constructed according to the principles of the present invention is illustrated in
The arrangement 190 may further comprise a means for securing the analyte quantification member 50 to the base 20. Suitable means for securing include an adhesive provided between the analyte quantification member 50 and the base 20, or one or more recess features provided on the base 20 which trap and/or contain the quantification member 50 therein, transparent adhesive tape placed over the quantification member 50 (not shown), or an integral or separate cover member disposed on the base overlying the quantification member 50. According to the illustrated embodiment, the means for securing the analyte quantification member 50 includes a cover 54, which overlies the analyte quantification member 50. The cover 54 may provide means for allowing optical communication with the analyte quantification member 50 lying below. Suitable means for providing optical communication includes forming the cover 54 entirely of a transparent or translucent material. Alternatively, the cover 54 may be formed with one or more windows 55 of a transparent or translucent material, and wherein the cover 54 may otherwise be formed from an opaque material. The cover 54 may be secured to the base 20 by any suitable means. Suitable securing means include fasteners, a press fit, snaps, latches, adhesives, and thermal bonding.
According to the illustrated arrangement 190, an optional spacer 56 may also be provided, which limits compression of the analyte quantification member 50. The optional spacer 56 is preferably formed such that it also permits optical communication with the analyte quantification member 50 lying below. The arrangement 190 may also comprise a counterbore 52 receiving the analyte quantification member 50 therein. This counterbore 52 also limits compression of the analyte quantification member 50 by the cover 54. It should be evident that the arrangement 190 may comprise either the counterbore 52 or the spacer 54 as an effective means of preventing over compression, and need not include both.
The arrangement 190 may further include one or more components typically provided for photometric detection and quantification of the analyte. For example, as illustrated in
Although not illustrated, the arrangement 200 may also comprise the above-described photometric detection components, such as a light source S, detection element D, and optional lens L as well as any other of the features associated with the previously described embodiments.
A modified arrangement 210 formed according to an alternative embodiment of the present invention is illustrated in
A further alternative arrangement of the present invention is illustrated in
The arrangement 230 provides certain advantages. For example, if the diameter of the analyte quantification members is larger than the larger diameter of the counter bore 60, the analyte quantification member 50 may still be conformed to and mounted within the counter bore 60, in the manner illustrated in
The arrangement 230 may also be provided with one, or a combination, of the previously described features.
A further alternative arrangement 240 constructed according to the present invention is depicted in
The arrangement 240 may further include an actuation member 70 which is mounted to the base 20 by any suitable mechanism. According to the illustrated embodiment, the actuation member 70 is disposed in a passageway extending through the hublike base 20 (see, e.g.,
An integrated device for sampling and testing a sample of body fluid for analyte concentration is formed according to the principles of the present invention may have a number of suitable configurations. According to certain embodiments the device is configured to perform testing by acquiring a sample of blood from the user, transfer the sample to an analysis site, and determine the concentration of glucose contained therein. These operations are all performed with little or no user input. For example, these operations may commence automatically according to a specified or predetermined schedule. Alternatively, these operations may commence at the command of the user via, for example, pressing a start button on the device.
The device may include disposable and reusable portions. The disposable portion may include at least one skin piercing element/transport member and analysis site (which may include an assay pad). The disposable portion may provide the capability to perform a single test. After testing is complete, the disposable portion is discarded and replaced with a new disposable portion before performing another test. Alternatively, the disposable portion includes a plurality of skin piercing elements/transport members and analysis sites. Such disposable units permit a plurality of tests to be performed before it is necessary to discard and replace the disposable unit. The device may be either wearable or handheld, or both.
A non-limiting exemplary integrated device 260 is illustrated in
The device 260 preferably includes at least one arrangement for performing a measurement of the concentration of an analyte contained in a sample of blood. According to the illustrated embodiment, the device 260 comprises at least one arrangement 240 as described herein comprising at least one skin-piercing element, at least one actuation member, such as a torsional spring element, and at least one analysis site which may contain an assay pad. The at least one arrangement may form part of a disposable portion or unit. According to one embodiment, the disposable unit allows for at least one measurement of the concentration of an analyte contained in a sample of blood prior to being discarded and replaced. According to a further embodiment, the disposable unit allows for a plurality of measurements of the concentration of an analyte contained in a sample of blood prior to being discarded and replaced.
Any of the arrangements and/or embodiments of the present invention may be utilized in devices of the type described above, either entirely or partially. Thus, various combinations of features described in connection with arrangements herein may be selected and utilized independently or together in a multitude of different combinations.
In addition, any of the arrangements described herein may be combined with additional fluid flow enhancing features, such as those described in U.S. Patent Application Publication No. US 2007-0078358, entitled FLUID SAMPLE TRANSPORT DEVICES AND METHODS, the entire content of which is incorporated herein by reference.
All of the above-described exemplary arrangements of the present invention may be used independently, or in combination with other devices and arrangements, and systems. Inclusion in other types of devices, wearable and non-wearable, are specifically contemplated by the present invention. Additional details of such discrete autonomous integrated testing devices may be gathered from the disclosure of U.S. Patent Application Ser. No. 60/721,966, entitled DEVICE FOR FLUID ANALYSIS WITH SAMPLE EXTRACTION AND TRANSPORT, the entire content of which is incorporated herein by reference.
According to the present invention, there is also provided methods for improving the transport of a fluid. The present invention also provides methods for improving the transport of body fluid by enhancing the capillary transport properties of a base or support member.
According to one aspect, the present invention comprises a method of improving transport of a fluid, such as a body fluid, comprising providing a base with a bore disposed therein extending from a first surface of the base through a second surface of the base; providing a fluid transport tube having a first end, a second end opposite the first end, and a lumen having an inner diameter, inserting at least the second end of the tube within the bore of the base; and disposing at least one fluid transport-enhancing groove comprising at least a first section in the second surface of the base such that it is in fluid communication with the bore.
The method may further comprise disposing an analyte quantification member in fluid communication with at least one of the bore and the at least one fluid transport enhancing groove. The quantification member may be located such that it is in direct fluid communication with at least one of the bore and the at least one fluid transport enhancing groove. The quantification member can comprise a fibrous membrane or assay pad containing a chemical reagent chosen to react with a predetermined analyte. The method may further include providing a cover overlying the quantification member. The cover can be constructed to permit optical communication with the quantification member. The cover may also be in the form of a cap. Methods of the present invention may further comprise providing a spacer interposed between the quantification member and the cover. A counterbore may also be formed in the second surface of the base receiving the quantification member therein. The counter bore may have at least one of a flat bottom and a curved bottom.
The method may further include providing the fluid transport tube in the front of a needle, wherein the first end of the needle is constructed for piercing the skin. The needle can be formed from a metal, and the base is formed, at least in part from a metal, a polymer, a glass, or a ceramic.
In any of the above-described methods, at least a portion of the lumen may comprise a fluid transport enhancing feature, such as at least one of a coating and a surface texture.
The methods of the present invention may include providing the bore with a first section extending from the first surface of the base and defining a counter bore receiving at least the second end of the fluid transport tube. The bore may also comprise a second section extending from the second end of the fluid transport tube to the second surface of the base.
In any of the above described methods, the at least one fluid transport enhancing groove may further comprise a second section disposed in the second section of the bore. The second section of the at least one groove can be substantially linear and extend longitudinally along the second section of the bore, or may be formed substantially as a spiral in the second section of the bore.
According to the methods of the present invention, at least one of the first and second sections of the groove can be provided with a geometrical cross-sectional configuration comprising a flat-bottomed groove, a curved-bottom groove, or a pointed-bottom groove. Optionally, at least one of the first and second sections of the groove comprises a cross-sectional area that decreases in the direction extending away from the second end of the needle.
Methods performed according to the present invention may further comprise providing a plurality of fluid transport enhancing grooves in the second surface of the base, and wherein at least two of the plurality of grooves may intersect the bore at the second surface of the base. The plurality of grooves may further comprise at least one groove disposed in the second surface of the base that intersects another of the plurality of grooves, but does not intersect the bore. Alternatively, or in addition, the at least one groove may tangentially intersect the bore along the second surface of the base. At least one of the first and second sections of the groove(s) may comprise a fluid transport-enhancing feature, the feature comprising at least one of a coating and a surface texture. The portion of the bore extending from the second end of the tube to the second surface may comprise an additional fluid transport enhancing feature, the feature comprising at least one of a coating and a surface texture.
According to the methods of the present invention, the base may comprise a generally cylindrical hub. An actuation member may be attached to the hub.
According to an alternative aspect of the present invention, a method for improving transport of a fluid, such as a body fluid, comprises providing a base having a bore disposed therein extending from a first surface of the base through a second surface of the base; providing a needle having a first end adapted to pierce the skin, a second end opposite the first end, and a lumen having an inner diameter, inserting at least the second end of the tube received within the bore of the base; disposing at least one fluid transport enhancing groove comprising at least a first section disposed in the second surface of the base in fluid communication with the bore; and providing an analyte quantification member in fluid communication with at least one of the bore and the at least one fluid transport enhancing groove.
According to the methods of the present invention, a wearable or hand held blood glucose monitor is formed and/or operated by a method comprising, at least in part, any of the above described methods.
While this invention is satisfied by embodiments in many different forms, as described in detail in connection with preferred embodiments of the invention, it is understood that the present disclosure is to be considered as exemplary of the principles of the invention and is not intended to limit the invention to the specific embodiments illustrated and described herein. Numerous variations may be made by persons skilled in the art without departure from the spirit of the invention. The scope of the invention will be measured by the appended claims and their equivalents. The abstract and the title are not to be construed as limiting the scope of the present invention, as their purpose is to enable the appropriate authorities, as well as the general public, to quickly determine the general nature of the invention. In the claims that follow, unless the term “means” is used, none of the features or elements recited therein should be construed as means-plus-function limitations pursuant to 35 U.S.C. §112, ¶6.
Number | Name | Date | Kind |
---|---|---|---|
842690 | Oswalt | Jan 1907 | A |
D137874 | Partridge | May 1944 | S |
2749797 | Harks | Mar 1950 | A |
3092465 | Adams, Jr. | Jun 1963 | A |
3310002 | Wilburn | Mar 1967 | A |
3620209 | Kravitz | Nov 1971 | A |
3623475 | Sanz et al. | Nov 1971 | A |
3626929 | Sanz et al. | Dec 1971 | A |
3630957 | Rey | Dec 1971 | A |
D223165 | Komendat | Mar 1972 | S |
3723064 | Liotta | Mar 1973 | A |
3741197 | Sanz et al. | Jun 1973 | A |
3961898 | Neeley et al. | Jun 1976 | A |
4014328 | Cluff et al. | Mar 1977 | A |
4042335 | Clement | Aug 1977 | A |
4057394 | Genshaw | Nov 1977 | A |
4109655 | Chacornac | Aug 1978 | A |
4254083 | Columbus | Mar 1981 | A |
4258001 | Pierce et al. | Mar 1981 | A |
4260257 | Neeley et al. | Apr 1981 | A |
4289459 | Neeley et al. | Sep 1981 | A |
4321397 | Nix et al. | Mar 1982 | A |
4350762 | DeLuca et al. | Sep 1982 | A |
4394512 | Batz | Jul 1983 | A |
4414975 | Ryder et al. | Nov 1983 | A |
4416279 | Lindner et al. | Nov 1983 | A |
4418037 | Katsuyama et al. | Nov 1983 | A |
4422941 | Vaughan, Jr. et al. | Dec 1983 | A |
4429700 | Thees et al. | Feb 1984 | A |
4627445 | Garcia et al. | Dec 1986 | A |
4637403 | Garcia et al. | Jan 1987 | A |
4637406 | Guinn et al. | Jan 1987 | A |
4653513 | Dombrowski | Mar 1987 | A |
4661319 | Lape | Apr 1987 | A |
4702261 | Cornell et al. | Oct 1987 | A |
4711250 | Gilbaugh, Jr. et al. | Dec 1987 | A |
4737458 | Batz et al. | Apr 1988 | A |
4767415 | Duffy | Aug 1988 | A |
4774192 | Terminiello et al. | Sep 1988 | A |
4790979 | Terminiello et al. | Dec 1988 | A |
4794926 | Munsch et al. | Jan 1989 | A |
4815843 | Tiefenthaler et al. | Mar 1989 | A |
4829470 | Wang | May 1989 | A |
4846785 | Cassou et al. | Jul 1989 | A |
4887306 | Hwang et al. | Dec 1989 | A |
4920977 | Haynes | May 1990 | A |
4930525 | Palestrant | Jun 1990 | A |
4935346 | Phillips | Jun 1990 | A |
4953552 | De Marzo | Sep 1990 | A |
4966646 | Zdeblick | Oct 1990 | A |
4995402 | Smith | Feb 1991 | A |
5029583 | Meserol | Jul 1991 | A |
5049487 | Phillips et al. | Sep 1991 | A |
5050617 | Columbus et al. | Sep 1991 | A |
5059394 | Phillips et al. | Oct 1991 | A |
5077199 | Basagni et al. | Dec 1991 | A |
5094943 | Siedel et al. | Mar 1992 | A |
5116759 | Klainer et al. | May 1992 | A |
5131404 | Neeley et al. | Jul 1992 | A |
5141868 | Shanks et al. | Aug 1992 | A |
5145565 | Kater et al. | Sep 1992 | A |
5146437 | Boucheron | Sep 1992 | A |
5153416 | Neeley | Oct 1992 | A |
5164575 | Neeley et al. | Nov 1992 | A |
5166498 | Neeley | Nov 1992 | A |
5174291 | Schoonen et al. | Dec 1992 | A |
5176632 | Bernardi | Jan 1993 | A |
5179005 | Phillips et al. | Jan 1993 | A |
5183741 | Arai et al. | Feb 1993 | A |
5196302 | Kidwell | Mar 1993 | A |
5208163 | Charlton et al. | May 1993 | A |
5213966 | Vuorinen et al. | May 1993 | A |
5217480 | Habar et al. | Jun 1993 | A |
5218966 | Yamasawa | Jun 1993 | A |
5223219 | Subramanian et al. | Jun 1993 | A |
5234818 | Zimmermann et al. | Aug 1993 | A |
5241969 | Carson et al. | Sep 1993 | A |
5251126 | Kahn et al. | Oct 1993 | A |
D341848 | Bigelow et al. | Nov 1993 | S |
5275159 | Griebel | Jan 1994 | A |
5278079 | Gubinski et al. | Jan 1994 | A |
5288646 | Lundsgaard et al. | Feb 1994 | A |
5299571 | Mastrototaro | Apr 1994 | A |
5301686 | Newman | Apr 1994 | A |
5302513 | Mike et al. | Apr 1994 | A |
5304468 | Phillips et al. | Apr 1994 | A |
5306623 | Kiser et al. | Apr 1994 | A |
5308767 | Terashima | May 1994 | A |
5320607 | Ishibashi | Jun 1994 | A |
5354537 | Moreno | Oct 1994 | A |
5360595 | Bell et al. | Nov 1994 | A |
5368047 | Suzuki et al. | Nov 1994 | A |
5383512 | Jarvis | Jan 1995 | A |
5390671 | Lord et al. | Feb 1995 | A |
5399316 | Yamada | Mar 1995 | A |
5401110 | Neeley | Mar 1995 | A |
5402798 | Swierczek et al. | Apr 1995 | A |
5441513 | Roth | Aug 1995 | A |
5451350 | Macho et al. | Sep 1995 | A |
5458140 | Eppstein et al. | Oct 1995 | A |
5460777 | Kitajima et al. | Oct 1995 | A |
5460968 | Yoshida et al. | Oct 1995 | A |
5482473 | Lord et al. | Jan 1996 | A |
5506200 | Hirschkoff et al. | Apr 1996 | A |
5507288 | Böcker et al. | Apr 1996 | A |
5508200 | Tiffany et al. | Apr 1996 | A |
5510266 | Bonner et al. | Apr 1996 | A |
5514152 | Smith | May 1996 | A |
5568806 | Cheney, II et al. | Oct 1996 | A |
5569287 | Tezuka et al. | Oct 1996 | A |
5575403 | Charlton et al. | Nov 1996 | A |
5577499 | Teves | Nov 1996 | A |
5582184 | Erickson et al. | Dec 1996 | A |
5586553 | Halili et al. | Dec 1996 | A |
5591139 | Lin et al. | Jan 1997 | A |
5611809 | Marshall et al. | Mar 1997 | A |
5624458 | Lipscher | Apr 1997 | A |
5630986 | Charlton et al. | May 1997 | A |
5632410 | Moulton et al. | May 1997 | A |
5636632 | Bommannan et al. | Jun 1997 | A |
5647851 | Pokras | Jul 1997 | A |
5658515 | Lee et al. | Aug 1997 | A |
5660791 | Brenneman et al. | Aug 1997 | A |
5676850 | Reed et al. | Oct 1997 | A |
5680858 | Hansen et al. | Oct 1997 | A |
5681484 | Zanzucchi et al. | Oct 1997 | A |
5682233 | Brinda | Oct 1997 | A |
5697901 | Eriksson | Dec 1997 | A |
5701181 | Boiarski et al. | Dec 1997 | A |
5701910 | Powles et al. | Dec 1997 | A |
5705018 | Hartley | Jan 1998 | A |
5708787 | Nakano et al. | Jan 1998 | A |
5715417 | Gardien et al. | Feb 1998 | A |
5730753 | Morita | Mar 1998 | A |
5735273 | Kurnik et al. | Apr 1998 | A |
5736103 | Pugh | Apr 1998 | A |
5741211 | Renirie et al. | Apr 1998 | A |
5746217 | Erickson et al. | May 1998 | A |
5746720 | Stouder, Jr. | May 1998 | A |
5757666 | Schreiber et al. | May 1998 | A |
5759364 | Charlton et al. | Jun 1998 | A |
5766066 | Ranniger | Jun 1998 | A |
5771890 | Tamada | Jun 1998 | A |
5797693 | Jaeger | Aug 1998 | A |
5801057 | Smart et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5820570 | Erickson et al. | Oct 1998 | A |
5827183 | Kurnik et al. | Oct 1998 | A |
5840020 | Heinonen et al. | Nov 1998 | A |
5841126 | Fossum et al. | Nov 1998 | A |
5843692 | Phillips et al. | Dec 1998 | A |
5846837 | Thym et al. | Dec 1998 | A |
5854074 | Charlton et al. | Dec 1998 | A |
D403975 | Douglas et al. | Jan 1999 | S |
5855801 | Lin et al. | Jan 1999 | A |
5856195 | Charlton et al. | Jan 1999 | A |
5858194 | Bell | Jan 1999 | A |
5866281 | Guckel et al. | Feb 1999 | A |
5871494 | Simons et al. | Feb 1999 | A |
5879310 | Sopp et al. | Mar 1999 | A |
5879326 | Godshall et al. | Mar 1999 | A |
5879367 | Latterell et al. | Mar 1999 | A |
5891053 | Sesekura | Apr 1999 | A |
5893870 | Talen et al. | Apr 1999 | A |
5911711 | Pelkey | Jun 1999 | A |
5911737 | Lee et al. | Jun 1999 | A |
5912139 | Iwata et al. | Jun 1999 | A |
5925021 | Castellano et al. | Jul 1999 | A |
5928207 | Pisano et al. | Jul 1999 | A |
5930873 | Wyser | Aug 1999 | A |
5938679 | Freeman et al. | Aug 1999 | A |
5945678 | Yanagisawa | Aug 1999 | A |
5951492 | Douglas et al. | Sep 1999 | A |
5951493 | Douglas et al. | Sep 1999 | A |
5954685 | Tierney | Sep 1999 | A |
5962215 | Douglas et al. | Oct 1999 | A |
5968760 | Phillips et al. | Oct 1999 | A |
5968765 | Grage et al. | Oct 1999 | A |
5971941 | Simons et al. | Oct 1999 | A |
5972294 | Smith et al. | Oct 1999 | A |
5986754 | Harding | Nov 1999 | A |
5989409 | Kurnik et al. | Nov 1999 | A |
5993189 | Mueller et al. | Nov 1999 | A |
6001067 | Shults et al. | Dec 1999 | A |
6005545 | Nishida et al. | Dec 1999 | A |
6010463 | Lauks et al. | Jan 2000 | A |
6010519 | Mawhirt et al. | Jan 2000 | A |
6014135 | Fernandes | Jan 2000 | A |
6014577 | Henning et al. | Jan 2000 | A |
6023629 | Tamada | Feb 2000 | A |
6027459 | Shain et al. | Feb 2000 | A |
6030827 | Davis et al. | Feb 2000 | A |
6032059 | Henning et al. | Feb 2000 | A |
6036924 | Simons et al. | Mar 2000 | A |
6041253 | Kost et al. | Mar 2000 | A |
6050988 | Zuck | Apr 2000 | A |
6056701 | Duchon et al. | May 2000 | A |
6056734 | Jacobsen et al. | May 2000 | A |
6058321 | Swayze et al. | May 2000 | A |
6059815 | Lee et al. | May 2000 | A |
6061128 | Zweig et al. | May 2000 | A |
6063039 | Cunningham et al. | May 2000 | A |
6071294 | Simons et al. | Jun 2000 | A |
6077660 | Wong et al. | Jun 2000 | A |
6080116 | Erickson et al. | Jun 2000 | A |
6083196 | Trautman et al. | Jul 2000 | A |
6086544 | Hibner et al. | Jul 2000 | A |
6090790 | Eriksson | Jul 2000 | A |
6091975 | Daddona et al. | Jul 2000 | A |
6093156 | Cunningham et al. | Jul 2000 | A |
6097831 | Wieck et al. | Aug 2000 | A |
6099484 | Douglas et al. | Aug 2000 | A |
6100107 | Lei et al. | Aug 2000 | A |
6102933 | Lee et al. | Aug 2000 | A |
6103033 | Say et al. | Aug 2000 | A |
6103197 | Werner | Aug 2000 | A |
6106751 | Talbot et al. | Aug 2000 | A |
6118126 | Zanzucchi | Sep 2000 | A |
6120676 | Heller et al. | Sep 2000 | A |
6123861 | Santini, Jr. et al. | Sep 2000 | A |
6126899 | Woudenberg et al. | Oct 2000 | A |
6132449 | Lum et al. | Oct 2000 | A |
6139562 | Mauze et al. | Oct 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6152942 | Brenneman et al. | Nov 2000 | A |
6162639 | Douglas | Dec 2000 | A |
6175752 | Say et al. | Jan 2001 | B1 |
6176865 | Mauze et al. | Jan 2001 | B1 |
6183434 | Eppstein | Feb 2001 | B1 |
6183489 | Douglas et al. | Feb 2001 | B1 |
6187210 | Lebouiz et al. | Feb 2001 | B1 |
6192891 | Gravel et al. | Feb 2001 | B1 |
6200296 | Dibiasi et al. | Mar 2001 | B1 |
6206841 | Cunningham et al. | Mar 2001 | B1 |
6214626 | Meller et al. | Apr 2001 | B1 |
6219574 | Cormier et al. | Apr 2001 | B1 |
6228100 | Schraga | May 2001 | B1 |
6230051 | Cormier et al. | May 2001 | B1 |
6231531 | Lum et al. | May 2001 | B1 |
6241862 | McAleer et al. | Jun 2001 | B1 |
6242207 | Douglas et al. | Jun 2001 | B1 |
6245215 | Douglas et al. | Jun 2001 | B1 |
6251083 | Yum et al. | Jun 2001 | B1 |
6251260 | Heller et al. | Jun 2001 | B1 |
6254586 | Mann et al. | Jul 2001 | B1 |
6255061 | Mori et al. | Jul 2001 | B1 |
6256533 | Yuzhakov et al. | Jul 2001 | B1 |
6268162 | Phillips et al. | Jul 2001 | B1 |
6271045 | Douglas et al. | Aug 2001 | B1 |
6272364 | Kurnik | Aug 2001 | B1 |
6283926 | Cunningham et al. | Sep 2001 | B1 |
6289230 | Chaiken et al. | Sep 2001 | B1 |
6298254 | Tamada | Oct 2001 | B2 |
6299578 | Kurnik et al. | Oct 2001 | B1 |
6309351 | Kurnik et al. | Oct 2001 | B1 |
D450711 | Istvan et al. | Nov 2001 | S |
6312612 | Sherman et al. | Nov 2001 | B1 |
6312888 | Wong et al. | Nov 2001 | B1 |
6322808 | Trautman et al. | Nov 2001 | B1 |
6329161 | Heller et al. | Dec 2001 | B1 |
6331266 | Powell et al. | Dec 2001 | B1 |
6332871 | Douglas et al. | Dec 2001 | B1 |
6334856 | Allen et al. | Jan 2002 | B1 |
6350273 | Minagawa et al. | Feb 2002 | B1 |
6352514 | Douglas et al. | Mar 2002 | B1 |
6356776 | Berner et al. | Mar 2002 | B1 |
6358265 | Thorne, Jr. et al. | Mar 2002 | B1 |
6364890 | Lum et al. | Apr 2002 | B1 |
6375626 | Allen et al. | Apr 2002 | B1 |
6375627 | Mauze et al. | Apr 2002 | B1 |
6379969 | Mauze et al. | Apr 2002 | B1 |
6391005 | Lum et al. | May 2002 | B1 |
6409679 | Pyo | Jun 2002 | B2 |
6428664 | Bhular et al. | Aug 2002 | B1 |
6449608 | Morita et al. | Sep 2002 | B1 |
6455324 | Douglas | Sep 2002 | B1 |
6500134 | Cassone | Dec 2002 | B1 |
6520973 | McGarry | Feb 2003 | B1 |
6530892 | Kelly | Mar 2003 | B1 |
6537243 | Henning et al. | Mar 2003 | B1 |
6540675 | Aceti et al. | Apr 2003 | B2 |
6544475 | Douglas et al. | Apr 2003 | B1 |
6555061 | Leong et al. | Apr 2003 | B1 |
6558624 | Lemmon et al. | May 2003 | B1 |
6579690 | Bonnecaze et al. | Jun 2003 | B1 |
6602205 | Erickson et al. | Aug 2003 | B1 |
6612111 | Hodges et al. | Sep 2003 | B1 |
6616616 | Fritz et al. | Sep 2003 | B2 |
6626874 | Duchamp | Sep 2003 | B1 |
6656167 | Numao et al. | Dec 2003 | B2 |
6679852 | Schmelzeisen-Redeker et al. | Jan 2004 | B1 |
6706000 | Perez et al. | Mar 2004 | B2 |
6706049 | Moerman | Mar 2004 | B2 |
6706159 | Moerman et al. | Mar 2004 | B2 |
6740800 | Cunningham | May 2004 | B1 |
6748275 | Lattner et al. | Jun 2004 | B2 |
6753187 | Cizdziel et al. | Jun 2004 | B2 |
6766817 | da Silva | Jul 2004 | B2 |
6793633 | Douglas et al. | Sep 2004 | B2 |
6830669 | Miyazaki et al. | Dec 2004 | B2 |
6836678 | Tu | Dec 2004 | B2 |
6837858 | Cunningham et al. | Jan 2005 | B2 |
6847451 | Pugh | Jan 2005 | B2 |
6918404 | Da Silva | Jul 2005 | B2 |
6919960 | Hansen et al. | Jul 2005 | B2 |
6923764 | Aceti et al. | Aug 2005 | B2 |
6936476 | Anderson et al. | Aug 2005 | B1 |
6988996 | Roe et al. | Jan 2006 | B2 |
7004928 | Aceti et al. | Feb 2006 | B2 |
7011630 | Desai et al. | Mar 2006 | B2 |
7025774 | Freeman et al. | Apr 2006 | B2 |
7066586 | Da Silva | Jun 2006 | B2 |
7066890 | Lam et al. | Jun 2006 | B1 |
7141058 | Briggs et al. | Nov 2006 | B2 |
7156809 | Quy | Jan 2007 | B2 |
7192061 | Martin | Mar 2007 | B2 |
D540343 | Cummins | Apr 2007 | S |
7223365 | Von Der Goltz | May 2007 | B2 |
7225008 | Ward et al. | May 2007 | B1 |
7226461 | Boecker et al. | Jun 2007 | B2 |
D551243 | Young | Sep 2007 | S |
7270970 | Anderson et al. | Sep 2007 | B2 |
7297151 | Boecker et al. | Nov 2007 | B2 |
7343188 | Sohrab | Mar 2008 | B2 |
7344507 | Briggs et al. | Mar 2008 | B2 |
7427377 | Zanzucchi et al. | Sep 2008 | B2 |
D599373 | Kobayashi et al. | Sep 2009 | S |
D601578 | Poulet et al. | Oct 2009 | S |
7682318 | Alden et al. | Mar 2010 | B2 |
7803123 | Perez et al. | Sep 2010 | B2 |
7887494 | Emery et al. | Feb 2011 | B2 |
D642191 | Barnett et al. | Jul 2011 | S |
20010001034 | Douglas | May 2001 | A1 |
20010027328 | Lum et al. | Oct 2001 | A1 |
20010053891 | Ackley | Dec 2001 | A1 |
20020002326 | Causey, III et al. | Jan 2002 | A1 |
20020002344 | Douglas et al. | Jan 2002 | A1 |
20020004640 | Conn et al. | Jan 2002 | A1 |
20020006355 | Whitson | Jan 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020020688 | Sherman et al. | Feb 2002 | A1 |
20020023852 | Mcivor et al. | Feb 2002 | A1 |
20020042594 | Lum et al. | Apr 2002 | A1 |
20020052618 | Haar et al. | May 2002 | A1 |
20020087056 | Aceti et al. | Jul 2002 | A1 |
20020136667 | Subramanian et al. | Sep 2002 | A1 |
20020137998 | Smart et al. | Sep 2002 | A1 |
20020160520 | Orloff et al. | Oct 2002 | A1 |
20020168290 | Yuzhakov et al. | Nov 2002 | A1 |
20020169394 | Eppstein et al. | Nov 2002 | A1 |
20020169411 | Sherman et al. | Nov 2002 | A1 |
20020177761 | Orloff et al. | Nov 2002 | A1 |
20020183102 | Withers et al. | Dec 2002 | A1 |
20020188223 | Perez et al. | Dec 2002 | A1 |
20020198444 | Uchigaki et al. | Dec 2002 | A1 |
20030012693 | Otillar et al. | Jan 2003 | A1 |
20030028087 | Yuzhakov et al. | Feb 2003 | A1 |
20030028125 | Yuzhakov et al. | Feb 2003 | A1 |
20030039587 | Niermann | Feb 2003 | A1 |
20030083685 | Freeman et al. | May 2003 | A1 |
20030083686 | Freeman et al. | May 2003 | A1 |
20030116596 | Terasawa | Jun 2003 | A1 |
20030135166 | Gonnelli | Jul 2003 | A1 |
20030135333 | Aceti | Jul 2003 | A1 |
20030153844 | Smith et al. | Aug 2003 | A1 |
20030153900 | Aceti et al. | Aug 2003 | A1 |
20030175987 | Verdonk et al. | Sep 2003 | A1 |
20030206302 | Pugh | Nov 2003 | A1 |
20030207441 | Eyster et al. | Nov 2003 | A1 |
20030208113 | Mault et al. | Nov 2003 | A1 |
20030211619 | Olson et al. | Nov 2003 | A1 |
20030212344 | Yuzhakov et al. | Nov 2003 | A1 |
20030212347 | Sohrab | Nov 2003 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040030353 | Schmelzeisen-redeker et al. | Feb 2004 | A1 |
20040049219 | Briggs et al. | Mar 2004 | A1 |
20040059256 | Perez | Mar 2004 | A1 |
20040073140 | Douglas | Apr 2004 | A1 |
20040092842 | Boecker et al. | May 2004 | A1 |
20040092995 | Boecker et al. | May 2004 | A1 |
20040096959 | Stiene et al. | May 2004 | A1 |
20040098009 | Boecker et al. | May 2004 | A1 |
20040102803 | Boecker et al. | May 2004 | A1 |
20040122339 | Roe | Jun 2004 | A1 |
20040132167 | Rule et al. | Jul 2004 | A1 |
20040138588 | Saikley et al. | Jul 2004 | A1 |
20040155084 | Brown | Aug 2004 | A1 |
20040178218 | Schomakers et al. | Sep 2004 | A1 |
20040186394 | Roe et al. | Sep 2004 | A1 |
20040191119 | Zanzucchi et al. | Sep 2004 | A1 |
20040202576 | Aceti et al. | Oct 2004 | A1 |
20040236251 | Roe et al. | Nov 2004 | A1 |
20040238675 | Banaszkiewicz et al. | Dec 2004 | A1 |
20050010134 | Douglas et al. | Jan 2005 | A1 |
20050015020 | LeVaughn et al. | Jan 2005 | A1 |
20050096686 | Allen | May 2005 | A1 |
20050106713 | Phan et al. | May 2005 | A1 |
20050159678 | Taniike et al. | Jul 2005 | A1 |
20050178218 | Montagu | Aug 2005 | A1 |
20050187532 | Thurau et al. | Aug 2005 | A1 |
20050202567 | Zanzucchi et al. | Sep 2005 | A1 |
20050202733 | Yoshimura et al. | Sep 2005 | A1 |
20050215872 | Berner et al. | Sep 2005 | A1 |
20050215923 | Wiegel | Sep 2005 | A1 |
20050245844 | Mace et al. | Nov 2005 | A1 |
20050277972 | Wong et al. | Dec 2005 | A1 |
20060008389 | Sacherer et al. | Jan 2006 | A1 |
20060036134 | Tarassenko et al. | Feb 2006 | A1 |
20060117616 | Jones et al. | Jun 2006 | A1 |
20060135873 | Karo et al. | Jun 2006 | A1 |
20060155317 | List | Jul 2006 | A1 |
20060178600 | Kennedy et al. | Aug 2006 | A1 |
20060189908 | Kennedy | Aug 2006 | A1 |
20060204399 | Freeman et al. | Sep 2006 | A1 |
20060229533 | Hoenes et al. | Oct 2006 | A1 |
20060241517 | Fowler et al. | Oct 2006 | A1 |
20060257993 | Mcdevitt et al. | Nov 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060281187 | Emery et al. | Dec 2006 | A1 |
20070017824 | Rippeth et al. | Jan 2007 | A1 |
20070078313 | Emery et al. | Apr 2007 | A1 |
20070078358 | Escutia et al. | Apr 2007 | A1 |
20070083131 | Escutia et al. | Apr 2007 | A1 |
20070179404 | Escutia et al. | Aug 2007 | A1 |
20070179405 | Emery et al. | Aug 2007 | A1 |
20070255181 | Alvarez-icaza et al. | Nov 2007 | A1 |
20070255302 | Koeppel et al. | Nov 2007 | A1 |
20080046831 | Imai et al. | Feb 2008 | A1 |
20080077048 | Escutia et al. | Mar 2008 | A1 |
20080194934 | Ray et al. | Aug 2008 | A1 |
20090156923 | Power et al. | Jun 2009 | A1 |
20100021948 | Lipman et al. | Jan 2010 | A1 |
20100095229 | Dixon et al. | Apr 2010 | A1 |
20100185120 | Sacherer et al. | Jul 2010 | A1 |
20120166090 | Lipman et al. | Jun 2012 | A1 |
Number | Date | Country |
---|---|---|
2 513 465 | Aug 2004 | CA |
199 22 413 | Nov 2000 | DE |
103 02-501 | Aug 2004 | DE |
0 396-016 | Nov 1990 | EP |
0 396-016 | Nov 1990 | EP |
0 255-338 | Feb 1998 | EP |
1 266-607 | Dec 2002 | EP |
1 266-607 | Dec 2002 | EP |
1 360-934 | Nov 2003 | EP |
1 360-934 | Nov 2003 | EP |
1 486 766 | Dec 2004 | EP |
1 529-489 | May 2005 | EP |
1 529-489 | May 2005 | EP |
1 769-735 | Apr 2007 | EP |
1 769 735 | Apr 2007 | EP |
63-305841 | Dec 1988 | JP |
3-63570 | Mar 1991 | JP |
03093189 | Apr 1991 | JP |
7-67861 | Mar 1995 | JP |
7-213925 | Aug 1995 | JP |
9-168530 | Jun 1997 | JP |
9-313465 | Sep 1997 | JP |
9-266889 | Oct 1997 | JP |
9-294737 | Nov 1997 | JP |
10-024028 | Jan 1998 | JP |
10-318970 | Dec 1998 | JP |
2000126161 | May 2000 | JP |
2000-168754 | Jun 2000 | JP |
2000-254111 | Sep 2000 | JP |
2001-159618 | Jun 2001 | JP |
2001-305096 | Oct 2001 | JP |
2001-330581 | Nov 2001 | JP |
2002-502045 | Jan 2002 | JP |
2002-514453 | May 2002 | JP |
2003-180417 | Jul 2003 | JP |
2004-000598 | Jan 2004 | JP |
2004-500948 | Jan 2004 | JP |
2004-117339 | Apr 2004 | JP |
2004-522500 | Jul 2004 | JP |
2004-528936 | Sep 2004 | JP |
2005-503538 | Feb 2005 | JP |
2005-087613 | Apr 2005 | JP |
2006-512969 | Apr 2005 | JP |
2005-525149 | Aug 2005 | JP |
2005-237938 | Sep 2005 | JP |
2005-525846 | Sep 2005 | JP |
2005-527254 | Sep 2005 | JP |
2006-512974 | Apr 2006 | JP |
2006-516723 | Jul 2006 | JP |
2006-521555 | Sep 2006 | JP |
2006-527013 | Nov 2006 | JP |
2007-521031 | Aug 2007 | JP |
WO-9114212 | Sep 1991 | WO |
WO-9413203 | Jun 1994 | WO |
WO-9510223 | Apr 1995 | WO |
WO-95-10223 | Apr 1995 | WO |
WO-9604857 | Feb 1996 | WO |
WO-9614026 | May 1996 | WO |
WO-9625088 | Aug 1996 | WO |
WO-9715227 | May 1997 | WO |
WO-9729847 | Aug 1997 | WO |
WO-9730344 | Aug 1997 | WO |
WO-9741421 | Nov 1997 | WO |
WO-9831275 | Jul 1998 | WO |
WO-9835225 | Aug 1998 | WO |
WO-9912008 | Mar 1999 | WO |
WO-9944508 | Sep 1999 | WO |
WO-9958051 | Nov 1999 | WO |
WO-0009184 | Feb 2000 | WO |
WO-0013573 | Mar 2000 | WO |
WO-0014269 | Mar 2000 | WO |
WO-0014535 | Mar 2000 | WO |
WO-0018449 | Apr 2000 | WO |
WO-0018449 | Apr 2000 | WO |
WO-0036400 | Jun 2000 | WO |
WO-0042422 | Jul 2000 | WO |
WO-0074763 | Dec 2000 | WO |
WO-0074763 | Dec 2000 | WO |
WO-0078208 | Dec 2000 | WO |
WO-0116575 | Mar 2001 | WO |
WO-0152727 | Jul 2001 | WO |
WO-0164105 | Sep 2001 | WO |
WO-0164105 | Sep 2001 | WO |
WO-0172220 | Oct 2001 | WO |
WO-0180728 | Nov 2001 | WO |
WO-0185233 | Nov 2001 | WO |
WO-0185233 | Nov 2001 | WO |
WO-0191634 | Dec 2001 | WO |
WO-0191634 | Dec 2001 | WO |
WO-0200101 | Jan 2002 | WO |
WO-0200101 | Jan 2002 | WO |
WO-0249507 | Jun 2002 | WO |
WO-0249509 | Jun 2002 | WO |
WO-0249509 | Jun 2002 | WO |
WO-02082052 | Oct 2002 | WO |
WO-02082052 | Oct 2002 | WO |
WO-02093144 | Nov 2002 | WO |
WO-02100251 | Dec 2002 | WO |
WO-02100251 | Dec 2002 | WO |
WO-02101359 | Dec 2002 | WO |
WO-02101359 | Dec 2002 | WO |
WO-03030984 | Apr 2003 | WO |
WO-03066128 | Aug 2003 | WO |
WO-03066128 | Aug 2003 | WO |
WO-03070099 | Aug 2003 | WO |
WO-03071940 | Sep 2003 | WO |
WO-03071940 | Sep 2003 | WO |
WO-2004062499 | Jul 2004 | WO |
WO-2004062500 | Jul 2004 | WO |
WO-2004062500 | Jul 2004 | WO |
WO-2004064636 | Aug 2004 | WO |
WO-2005006939 | Jan 2005 | WO |
WO-2005006939 | Jan 2005 | WO |
WO-2005009238 | Feb 2005 | WO |
WO-2005018709 | Mar 2005 | WO |
WO-2005018709 | Mar 2005 | WO |
WO-2005084546 | Sep 2005 | WO |
WO-2005084546 | Sep 2005 | WO |
WO-2005085995 | Sep 2005 | WO |
WO-2005084546 | Apr 2007 | WO |
WO-2005084546 | Apr 2007 | WO |
WO-2007041063 | Apr 2007 | WO |
WO-2007041063 | Apr 2007 | WO |
WO-2007041244 | Apr 2007 | WO |
WO-2007041244 | Apr 2007 | WO |
WO-2007041287 | Apr 2007 | WO |
WO-2007041287 | Apr 2007 | WO |
WO-2007041355 | Apr 2007 | WO |
WO-2007041355 | Apr 2007 | WO |
Entry |
---|
European Examination Report mailed on Mar. 18, 2011, for EP Patent Application No. 06 815 329.5 filed on Sep. 26, 2006, five pages. |
ADA Consensus Development Panel. (Jan.-Feb. 1987). “Consensus Statement on Self-Monitoring of Blood Glucose,” Diabetes Care 10(1):95-99. |
ADA (Jan. 1994). “Self-Monitoring of Blood Glucose,” Consensus Statement Diabetes Care 17(1):81-86. |
Anonymous. (Sep. 30, 1993). “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.” The New England Journal of Medicine 329(14):977-986. |
Anonymous. (Jun. 23, 1998). Taking the “Ouch” Out of Needles: Arrays of “Microneedles” Offer New Techniques for Drug Delivery, Science Daily, located at <http:www.sciencedaily.com/releases/1998/06/980623045850.htm>, last visited Jan. 14, 2014, 3 pages. |
Beregszàszi, M. et al. (Jul. 1997). “Nocturnal Hypoglycemia in Children and Adolescents with Insulin-Dependent Diabetes Mellitus: Prevalence and Risk Factors,” J. Pediatrics 131(1 Pt. 1):27-33. |
Chase, H.P. et al. (Feb. 2001). “Continuous Subcutaneous Glucose Monitoring in Children with Type 1 Diabetes,” Pediatrics 107(2):222-226. |
Clarke, W.L. et al. (Sep.-Oct. 1987). “Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,” Diabetes Care 10(5):622-628. |
Cox, D.J. et al. (Jun. 1997). “Understanding Error Grid Analysis,” Diabetes Care 20(6):911-912. |
D'Arrigo, T.D. (Mar. 2000). “GlucoWatch Monitor Poised for Approval,” Diabetes Forecast, 53(3):43-44. |
European Examination Report mailed on Jul. 19, 2012, for EP Patent Application No. 06 815 329.5 filed on Sep. 26, 2006, five pages. |
International Search Report mailed on Aug. 20, 2007 for PCT Application No. PCT/US2006/37245, filed on Sep. 26, 2006, 1 page. |
Johnson, R.N. et al. (Jan. 1998). “Accuracy of Devices Used for Self-Monitoring of Blood Glucose,” Annals of Clinical Biochemistry 35(1):68-74. |
Johnson, R.N. et al. (Jan. 1999). “Analytical Error of Home Glucose Monitors: A Comparison of 18 Systems,” Annals of Clinical Biochemistry 36(1):72-79. |
Johnson, R.N. et al. (2001). “Error Detection and Measurement in Glucose Monitors,” Clinica Chimica Acta 307:61-67. |
Lee, S-C. (Jun. 1999). “Light Scattering by Closely Spaced Parallel Cylinders Embedded in a Finite Dielectric Slab,” Journal of the Optical Society of America A 16(6):1350-1361. |
McNichols, R.J. et al. (Jan. 2000). “Optical Glucose Sensing in Biological Fluids: An Overview,” Journal of Biomedical Optics, 5(1):5-16. |
Medline Plus. (Jun. 17, 2008). , Medical Encyclopedia, Monitor Blood Glucose-Series: Part 1-4, 6 pages. |
Pfohl, M. et al. (2000). “Spot Glucose Measurement in Epidermal Interstitial Fluid—An Alternative to Capillary Blood Glucose Estimation,” Experimental and Clinical Endocrinology & Diabetes 108(1):1-4. |
Princen, H.M. (May 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, I. Capillary Rise Between Two Cylinders,” Journal of Colloid and Interface Science 30(1):69-75. |
Princen, H.M. (Jul. 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, II. Capillary Rise in Systems with More Than Two Cylinders,” Journal of Colloid and Interface Science 30(3):359-371. |
Rebrin, K. et al. (Sep. 1999). “Subcutaneous Glucose Predicts Plasma Glucose Independent of Insulin: Implications for Continuous Monitoring,” American Journal of Physiology 277(3):E561-E571. |
Trinder, P. (1969). “Determination of Glucose in Blood Using Glucose Oxidase with an Alternate Oxygen Acceptor,” Annals of Clinical Biochemistry 6:24-28. |
Written Opinion mailed on Aug. 20, 2007 for PCT Application No. PCT/US2006/37245, filed on Sep. 26, 2006, 7 pages. |
Collison, M.E. et al. (Sep. 1999). “Analytical Characterization of Electrochemical Biosensor Test Strips for Measurement of Glucose in Low-Volume Interstitial Fluid Samples,” Clinical Chemistry 45(9):1665-1673. |
Feldman, B. et al. (2000). “FreeStyle™: A Small-Volume Electrochemical Glucose Sensor for Home Blood Glucose Testing,” Diabetes Technology and Therapeutics, 2(2):221-229. |
Kumetrix, Inc. (Dec. 1999). “Painless Blood Glucose Monitoring, Courtesy of the Mosquito,” Start-Up pp. 27-28. |
Mahler, R.J. et al. (1999). “Clinical Review 102, Type 2 Diabetes Melitus: Update on Diagnosis Pathophysiology, and Treatment,” The Journal of Clinical Endocrinology and Metabolism 84(4):1165-1171. |
McGarraugh, G. et al. (2001). “Physiological Influences on Off-Finger Glucose Testing,” Diabetes Technology & Therapeutics 3(3):367-376. |
Neeley, W.E. et al. (1981). “An Instrument for Digital Matrix Photometry,” Clinical Chemistry 27(10):1665-1668. |
Neeley, W.E. (1983). “Reflectance Digital Matrix Photometry,” Clinical Chemistry 29(6):1038-1041. |
Neeley, W.E. (1983). “Multilayer Film Analysis for Glucose in 1- μL Samples of Plasma,” Clinical Chemistry 29(12):2103-2105. |
Neeley, W.E. (1988). “A Reflectance Photometer with a Square Photodiode Array Detector for Use on Multilayer Dry-Film Slides,” Clinical Chemistry 34(11):2367-2370. |
Otto, E. et al. (2000). “An Intelligent Diabetes Software Prototype: Predicting Blood Glucose Levels and Recommending Regimen Changes,” Diabetes Technology and Therapeutics 2(4):569-576. |
Smart, W.H. et al. (2000). “The Use of Silicon Microfabrication Technology in Painless Glucose Monitoring, ”Diabetes Technology & Therapeutics 2(4):549-559. |
Svedman, C. et al. (Apr. 1999). “Skin Mini-Erosion Technique for Monitoring Metabolites in Interstitial Fluid: Its Feasibility Demonstrated by OGTT Results in Diabetic and Non-Diabetic Subjects,” Scand. J. Clin. Lab. Invest. 59(2):115-123. |
Yum, S. I. et al. (Nov. 1, 1999). “Capillary Blood Sampling for Self-Monitoring of Blood Glucose,” Diabetes Technology & Therapeutics, 1(1):29-37. |
Number | Date | Country | |
---|---|---|---|
20070078358 A1 | Apr 2007 | US |